Equity Insider – Daily News Podcast Briefings

News EN ↓ 7 episodes

Equity Insider provides daily market news briefings and analysis, highlighting key developments across the global news and business sectors. Episodes are designed to keep listeners informed with timely, data-driven insights.

Author

Equity Insider – Daily News Podcast Briefings

Episodes

Protecting the Supply: North America’s Next Generation of Strategic Mineral Leaders 22.01.2026 1:58

https://markets-headlines.com/wp-content/uploads/2026/01/Protecting-the-Supply-North-Americas-Next-Generation-of-Strategic-Mineral-Leaders-1.mp4 The post Protecting the Supply: North America’s Next Generation of Strategic Mineral Leaders appeared first on markets-headlines .

Infrastructure Pivot Unlocks Margin Expansion: Operational Grit Triggers 2026 Asset Re-Rating 20.01.2026 1:37

Issued on behalf of RUA GOLD Inc. VANCOUVER, BC, Jan. 20, 2026 — Equity Insider News Commentary – The global mining sector is undergoing a structural realignment as producer margins expand to record levels, with top-tier firms now reporting All-In Sustaining Costs (AISC) below $1,500 per ounce[1] while gold trades near historic $4,700 resistance. As […] The post Infrastructure Pivot Un...

Functional Force: Precision Platforms Disrupt the 2026 Tumor Landscape 16.01.2026 1:32

Issued on behalf of GT Biopharma, Inc. VANCOUVER, BC, Jan. 16, 2026 — Equity Insider News Commentary – The precision medicine sector is undergoing a structural realignment toward platform-based biologics, as the market prepares to surge from $138 billion this year to over $537 billion by 2035[1]. This shift marks the end of “one-size-fits-all” treatments, […] The post Funct...

Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff 14.01.2026 1:50

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Jan. 14, 2026 — Equity-Insider.com News Commentary – The precision oncology market is hitting a massive growth spurt, projected to rocket from $110 billion toward a staggering $225.65 billion by 2032[1]. This gold rush is accelerating as Big Pharma giants scramble to survive a looming $170 […] The post Precision Killers: Why Bi...

Sovereign Defense Boom: The €381 Billion Shift to Local Military Tech 12.01.2026 1:19

Issued on behalf of VisionWave Holdings, Inc. VANCOUVER, BC, Dec. 24, 2025– Equity Insider News Commentary – European and NATO allies confirmed a credible pathway to achieving 5% GDP defense spending by 2035 at the December 3 NATO Foreign Ministers meeting, reinforcing the strategic imperative for Allied nations to localize military production and reduce reliance […] The post Sovereign...

The New Arms Race: Investing in Speed, Agility, and Responsive Space Infrastructure 11.01.2026 1:08

Issued on behalf of Starfighters Space, Inc. Equity Insider News Commentary VANCOUVER, BC, Jan. 2, 2026 -Equity Insider- As global adversaries field operational hypersonic vehicles, the U.S. has reached a ‘Sputnik moment’ for tactical space access. With the Pentagon committing over $6.9 billion to hypersonic weapons development for FY 2025[1], the market is no longer […] The post...

Gene Therapy: 5 Biotech Stocks Chasing the $36B Prize 11.01.2026 2:31

Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, Jan. 2, 2026 – Equity Insider News Commentary – The gene therapy market is surging toward $36.55 billion by 2032, powered by rising demand for curative treatments that target genetic diseases at their source[1]. The FDA approved three transformative cell therapies this December alone, marking an […] The post Gene Therapy: 5 Bio...